Arkolith/Insider Trading/KTTA/Form 4

Marques Tiago

Chief Executive Officer, DirectorPasithea Therapeutics Corp. (KTTA) · full profile →Form 4 · filed Nov 28, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2022Grant(A)2K$1.03$2K819K
Nov 23, 2022Grant(A)1K$1.02$1K817K
Nov 23, 2022Grant(A)1K$1.03$1K816K
Nov 23, 2022Grant(A)5K$1.00$5K815K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-075490) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML